stocksbrew
Pulse
Daily
Social
Radar
Pulse
Daily
Social
Radar
stocksbrew.

Stock watchlist guidance and alerts for the US stocks you follow.

Live now

Product

  • Market Pulse
  • Social
  • Radar
  • Pre-market movers
  • Market Daily
  • Earnings
  • US stocks
  • Stock sectors
  • AI agent access

Free tools

  • All free tools
  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Position calculator
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Stock analysis apps
  • Fundamental analysis
  • Earnings template
  • Use cases
  • Compare stocksbrew
  • Developer API

Company

  • About
  • Editorial policy
  • Author
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy
  • Cookie policy
  • Disclaimer
stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchFeatured on DanielLaunchesLaunched on FazierStocksBrew - Featured on Startup FameFeatured on ToolPilot.aiFeatured on Wired BusinessFeatured on Twelve ToolsFeatured on Aura++Listed onAI Toolz DirFeatured on Dofollow.ToolsFeatured on Hi CyouVerified on directreeListed on Huzzler
Listed onAI Toolz Dir

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

HU
HUMA stock logo

HUMA

Humacyte, Inc.

$0.68

▲ +4.41%

+$0.03

NASDAQ · Healthcare · Biotechnology

· price updated 9h ago

HU
HUMA stock logo

Humacyte, Inc.

HUMA · NASDAQ · Healthcare · Biotechnology · price updated 9h ago

$0.68

▲ +4.41% · +$0.03 today

DecisionEvidence

AI research · $0.68

Track HUMA for continuous AI research

price position

Where HUMA sits now

52-week range
Low$0.55
High$2.84
Today $0.68
RSI (14)
51.0Neutral
03070100
fundamentals

Business quality and valuation

overall score

54.8/100

Compared with sector peers · 83% coverage

key figures

P/E (TTM)n/a
EPS next Y+27.6%
Beta2.52
Market cap$176.18M

ttm snapshot

Revenue

$2.02M

Net income

$-75.32M

EPS

$-0.57

Op. income

$-113.89M

Gross profit

$-9.58M

Operating record

What the business has actually produced

Revenue

Capital structure

Cash versus debt

Cash & investments$48.5M
Total debt$65.9M
Net cash after debt$-17.4M

Valuation

What the market charges

Forward P/E

Price against expected earnings

No signal · Not enough data to judge

-

Price / sales

Value assigned to each sales dollar

Rich · Above 8x annual sales

87.39x

Price / FCF

Price against free cash generation

No signal · Not enough data to judge

-

EV / EBITDA

Operating value including debt

No signal · Not enough data to judge

-

Quality

How efficiently it compounds

ROIC

Return earned on invested capital

Weak · Below 8% return on capital

-71.5%

ROE

Profit generated from shareholder equity

Needs attention · Among weakest in sector

-409.5%

Debt / equity

Balance-sheet leverage

Needs attention · Among weakest in sector

5.72x

Current ratio

Short-term assets against liabilities

Strong · Comfortable short-term liquidity

3.93x

Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.

peer comparison

How HUMA compares

companymkt capP/Erev growthscore
HU
HUMA stock logo
HUMAHumacyte, Inc.
$176.18M--55
GM
GMED stock logo
GMEDGlobus Medical
$10.69B18.4+23.5%78
IN
INDV stock logo
INDVIndivior
$4.88B20.3+10.3%77
DX
DXCM stock logo
DXCMDexcom
$31.49B32.9+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.08T41.4+47.4%76

US stock research

About Humacyte, Inc. (HUMA) stock

Humacyte, Inc. trades on NASDAQ under the ticker HUMA. HUMA was +4.4% in the latest available session at $0.68. Its reported market value was $176.18M with a trailing P/E of 0.0. Latest reported revenue was $2.02M, with $-75.32M in net income.

Market snapshot updated Aug 3, 2026, 7:59 PM UTC.

Latest available price
$0.68
Day change
+4.4%
Market cap
$176.18M
P/E (TTM)
0.0
Industry
Biotechnology
Browse US stocksHealthcare analysisEarnings calendarCompare stocksFundamental analysis guideP/E ratio guideFree cash flow vs net incomeProfit margins explained